BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 32047496)

  • 1. Macrophage Phenotype and Function in Liver Disorder.
    Dou L; Shi X; He X; Gao Y
    Front Immunol; 2019; 10():3112. PubMed ID: 32047496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting hepatic macrophages to treat liver diseases.
    Tacke F
    J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases.
    van der Heide D; Weiskirchen R; Bansal R
    Front Immunol; 2019; 10():2852. PubMed ID: 31849997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major roles of kupffer cells and macrophages in NAFLD development.
    Park SJ; Garcia Diaz J; Um E; Hahn YS
    Front Endocrinol (Lausanne); 2023; 14():1150118. PubMed ID: 37274349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Polarization and Its Role in Liver Disease.
    Wang C; Ma C; Gong L; Guo Y; Fu K; Zhang Y; Zhou H; Li Y
    Front Immunol; 2021; 12():803037. PubMed ID: 34970275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Myeloid-Derived Cells in the Progression of Liver Disease.
    Weston CJ; Zimmermann HW; Adams DH
    Front Immunol; 2019; 10():893. PubMed ID: 31068952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
    Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
    Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease.
    Slevin E; Baiocchi L; Wu N; Ekser B; Sato K; Lin E; Ceci L; Chen L; Lorenzo SR; Xu W; Kyritsi K; Meadows V; Zhou T; Kundu D; Han Y; Kennedy L; Glaser S; Francis H; Alpini G; Meng F
    Am J Pathol; 2020 Nov; 190(11):2185-2193. PubMed ID: 32919978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
    Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
    Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hepatic macrophages in liver metastasis.
    Keirsse J; Van Damme H; Geeraerts X; Beschin A; Raes G; Van Ginderachter JA
    Cell Immunol; 2018 Aug; 330():202-215. PubMed ID: 29661474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages in the Aging Liver and Age-Related Liver Disease.
    Stahl EC; Haschak MJ; Popovic B; Brown BN
    Front Immunol; 2018; 9():2795. PubMed ID: 30555477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring liver macrophages using nanobodies targeting Vsig4: concanavalin A induced acute hepatitis as paradigm.
    Zheng F; Devoogdt N; Sparkes A; Morias Y; Abels C; Stijlemans B; Lahoutte T; Muyldermans S; De Baetselier P; Schoonooghe S; Beschin A; Raes G
    Immunobiology; 2015 Feb; 220(2):200-9. PubMed ID: 25440182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation.
    Reid DT; Reyes JL; McDonald BA; Vo T; Reimer RA; Eksteen B
    PLoS One; 2016; 11(7):e0159524. PubMed ID: 27454866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells attenuate sepsis-induced liver injury via inhibiting M1 polarization of Kupffer cells.
    Liang X; Li T; Zhou Q; Pi S; Li Y; Chen X; Weng Z; Li H; Zhao Y; Wang H; Chen Y
    Mol Cell Biochem; 2019 Feb; 452(1-2):187-197. PubMed ID: 30178273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex function of macrophages and their subpopulations in metabolic injury associated fatty liver disease.
    Subramanian P; Chavakis T
    J Physiol; 2023 Apr; 601(7):1159-1171. PubMed ID: 36825510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma.
    Vanderborght B; De Muynck K; Gijbels E; Lefere S; Scott CL; Guilliams M; Beschin A; Vinken M; Verhelst X; Geerts A; Van Vlierberghe H; Devisscher L
    Int J Cancer; 2023 Jun; 152(12):2615-2628. PubMed ID: 36912275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving story of macrophages in acute liver failure.
    Yang Q; Shi Y; He J; Chen Z
    Immunol Lett; 2012 Sep; 147(1-2):1-9. PubMed ID: 22820147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Macrophages in Liver Fibrosis.
    Sun C; Matsukawa A
    Acta Med Okayama; 2024 Feb; 78(1):1-8. PubMed ID: 38419308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance.
    Roohani S; Tacke F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.